FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency’s ...

Ticker: Americans putting money in investment income; FDA names former pharmaceutical company executive to oversee US drug ...

Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the agency’s ...

Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing ...

The U.S. Food and Drug Administration named ex-biotech exec George Tidmarsh as its chief drug regulator. FDA Commissioner ...

George Tidmarsh, a Stanford University physician who founded Horizon Pharma and later ran La Jolla Pharma, was named head of ...

The Food and Drug Administration on Monday named George Tidmarsh, a longtime biotech executive who has a background in ...

Michelle Xia gained experience at U.S. pharmaceutical firms before launching her own biotech company back home in China. In a ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

In an industry where 90 percent of drug candidates fail before reaching the market, a handful of startups are betting ...

Top experts from Amgen, CBIZ & Intrepid discuss 2025 trends in healthcare, biotech, and life sciences. Explore key insights ...